Literature DB >> 10790870

P2X3 receptor in injured human sensory neurons.

Y Yiangou1, P Facer, R Birch, L Sangameswaran, R Eglen, P Anand.   

Abstract

The ATP-gated cation channel P2X3 is expressed selectively by rat sensory neurones, and may play a role in nociception by binding ATP released from damaged or inflamed tissues. However, the distribution of this channel in human sensory neurons is not known. Using a specific antibody, we have demonstrated intense P2X3 immunoreactivity within a subset (60%) of small/medium diameter sensory neurones and fine nerve fibres in intact post-mortem human dorsal root ganglia (DRG). Co-localization studies showed < 15% overlap with the trkA immunostaining in DRG, indicating that P2X3 was expressed predominantly in sensory neurons that are also isolectin B4 positive. There was a significant decrease in numbers of P2X3-like immunoreactive neurons in human DRG after central axotomy (to 36%), similar to the decrease in rat DRG after peripheral axotomy. However, Western blotting demonstrated a specific 66 kDa band in human DRG and peripheral organs, including intestine, where histochemistry showed P2X3 immunoreactivity in myenteric plexus neurons. Thus P2X3 antagonists may be analgesic, but are unlikely to have a selective effect on pain in humans.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10790870     DOI: 10.1097/00001756-200004070-00019

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  13 in total

Review 1.  Molecular and functional properties of P2X receptors--recent progress and persisting challenges.

Authors:  Karina Kaczmarek-Hájek; Eva Lörinczi; Ralf Hausmann; Annette Nicke
Journal:  Purinergic Signal       Date:  2012-05-01       Impact factor: 3.765

Review 2.  P2X3 receptor involvement in pain states.

Authors:  Kerstin Wirkner; Beata Sperlagh; Peter Illes
Journal:  Mol Neurobiol       Date:  2007-07-17       Impact factor: 5.590

3.  Prenatal expression of purinergic receptor P2X3 in human dorsal root ganglion.

Authors:  Aihua Pan; Haiping Wu; Ming Li; Dahua Lu; Xu He; Xinan Yi; Xiao-Xin Yan; Zhiyuan Li
Journal:  Purinergic Signal       Date:  2011-11-04       Impact factor: 3.765

4.  Heterogeneity of the functional expression of P2X3 and P2X2/3 receptors in the primary nociceptive neurons of rat.

Authors:  U V Lalo; A N Dashkin; A Krishtal
Journal:  Neurochem Res       Date:  2001-09       Impact factor: 3.996

5.  Localization of P2X7 receptor immunoreactivity in the dorsal root ganglia of guinea pig.

Authors:  Xuegong Bai; Ling Jiang; Zhenghua Xiang
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

Review 6.  Crossing the pain barrier: P2 receptors as targets for novel analgesics.

Authors:  C Kennedy; T S Assis; A J Currie; E G Rowan
Journal:  J Physiol       Date:  2003-09-26       Impact factor: 5.182

7.  Distribution of P2X(3) receptor immunoreactivity in myenteric ganglia of the mouse esophagus.

Authors:  Christine Kestler; Winfried L Neuhuber; Marion Raab
Journal:  Histochem Cell Biol       Date:  2008-09-20       Impact factor: 4.304

8.  Altered expression of P2X3 in vagal and spinal afferents following esophagitis in rats.

Authors:  Banani Banerjee; Bidyut K Medda; Jamie Schmidt; Yue Zheng; Zhihong Zhang; Reza Shaker; Jyoti N Sengupta
Journal:  Histochem Cell Biol       Date:  2009-09-26       Impact factor: 4.304

9.  Differential expression and pharmacology of native P2X receptors in rat and primate sensory neurons.

Authors:  Alexandre Serrano; Gary Mo; Rebecca Grant; Michel Paré; Dajan O'Donnell; Xiao Hong Yu; Miroslaw J Tomaszewski; Martin N Perkins; Philippe Séguéla; Chang Qing Cao
Journal:  J Neurosci       Date:  2012-08-22       Impact factor: 6.167

10.  Dissociation between the relief of skeletal pain behaviors and skin hypersensitivity in a model of bone cancer pain.

Authors:  Jean-Marc G Guedon; Geraldine Longo; Lisa A Majuta; Michelle L Thomspon; Michelle N Fealk; Patrick W Mantyh
Journal:  Pain       Date:  2016-06       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.